Phase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancer
拉帕替尼联合长春瑞滨作为一线或二线治疗HER2过表达转移性乳腺癌女性患者的II期研究
期刊:Springerplus
影响因子:
doi:10.1186/2193-1801-3-108
Chew, Helen Kent; Schwartzberg, Lee; Badarinath, Suprith; Rubin, Peter; Shumaker, Grace; Daugherty, James; DeSilvio, Michelle; Mahoney, Janine